Analizan el potencial de los frmacos GLP-1 para tratar enfermedades ms all de la obesidad Un artculo publicado hoy en la revista Science analiza el potencial de los frmacos basados en el pptido similar al glucagn tipo 1 (GLP-1), como la semaglutida, a la hora de tratar enfermedades que van ms all de la diabetes y la obesidad
Semaglutide is typically administered once weekly through a small injection in areas such as the abdomen, thigh, or upper arm
Additionally, Neurobion can be excreted into breast milk, and while the risks of overdose in newborns are not yet clear, high doses of Vitamin B6 (over 600mg per day) may cause a reduction in or cessation of breast milk production
However, its essential to approach it as part of a comprehensive weight management plan, including diet, exercise, and regular medical check-ups